Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Jan;93(1):195–203. doi: 10.1172/JCI116945

Lovastatin increases arachidonic acid levels and stimulates thromboxane synthesis in human liver and monocytic cell lines.

N Hrboticky 1, L Tang 1, B Zimmer 1, I Lux 1, P C Weber 1
PMCID: PMC293753  PMID: 8282787

Abstract

The effect of lovastatin (LOV), the inhibitor of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase, on linoleic acid (LA, 18:2n-6) metabolism was examined in human monocytic Mono Mac 6 (MM6) and hepatoma Hep G2 cells. The desaturation of LA was examined after LOV (72 h, 10 microM) or dimethylsulfoxide (LOV carrier, < 0.1%) and [14C]LA (last 18 h, 0.3 microCi, 5 microM). In both cell lines, LOV reduced the percentage of 14C label associated with LA and increased the percentage of label in the 20:4n-6 and the 22:5n-6 fractions. In Hep G2 but not MM6 cells, this effect was fully reversible by means of coincubation with mevalonic acid (500 microM), but not with cholesterol or lipoproteins. In both cell lines, the LOV-mediated increase in LA desaturation resulted in dose-dependent reductions of LA and elevations of AA in cellular phospholipids. The lipids secreted by LOV-treated Hep G2 cells were also enriched in arachidonic acid (AA). In the MM6 cells, LOV increased release of thromboxane upon stimulation with the calcium ionophore A23187. In summary, our findings of higher LA desaturation and AA enrichment of lipids secreted by the Hep G2 cells suggest that LOV treatment may increase the delivery of AA from the liver to extrahepatic tissues. The changes in membrane fatty acid composition can influence a variety of cellular functions, such as eicosanoid synthesis in monocytic cells. The mechanism appears to be related to the reduced availability of intermediates of cholesterogenesis.

Full text

PDF
195

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agheli N., Jacotot B. Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients. Br J Clin Pharmacol. 1991 Oct;32(4):423–428. doi: 10.1111/j.1365-2125.1991.tb03925.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anel A., Naval J., González B., Uriel J., Piñeiro A. Fatty acid metabolism in human lymphocytes. II. Activation of fatty acid desaturase-elongase systems during blastic transformation. Biochim Biophys Acta. 1990 Jun 14;1044(3):332–339. doi: 10.1016/0005-2760(90)90077-b. [DOI] [PubMed] [Google Scholar]
  3. Basu S. K., Goldstein J. L., Anderson G. W., Brown M. S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3178–3182. doi: 10.1073/pnas.73.9.3178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beitz J., Hoffmann P., Taube C., Beitz A., Förster W. Low density lipoproteins of male donors decrease prostacyclin (PGI2) and enhance thromboxane (TXA2) release from rat aortas perfused under pulsatile pressure. Biomed Biochim Acta. 1985;44(11-12):1681–1686. [PubMed] [Google Scholar]
  5. Beitz J., Panse M., Förster W. Low density lipoprotein (LDL) from male volunteers stimulated the thromboxane formation by human platelets. Prostaglandins Leukot Med. 1983 Apr;10(4):443–448. doi: 10.1016/0262-1746(83)90056-2. [DOI] [PubMed] [Google Scholar]
  6. Borlakoglu J. T., Edwards-Webb J. D., Dils R. R. Evidence for the induction of fatty acid desaturation in proliferating hepatic endoplasmic reticulum in response to treatment with polychlorinated biphenyls. Are fatty acid desaturases cytochrome P-450-dependent monooxygenases? Int J Biochem. 1991;23(9):925–931. doi: 10.1016/0020-711x(91)90081-w. [DOI] [PubMed] [Google Scholar]
  7. Brenner R. R. Role of cholesterol in the microsomal membrane. Lipids. 1990 Oct;25(10):581–585. doi: 10.1007/BF02536005. [DOI] [PubMed] [Google Scholar]
  8. Cabot M. C., Welsh C. J. Fatty acid metabolism in phorbol ester-differentiating human leukemia cells. Cancer Res. 1981 Dec;41(12 Pt 1):4910–4915. [PubMed] [Google Scholar]
  9. Deanin G. G., Cutts J. L., Pfeiffer J. R., Oliver J. M. Role of isoprenoid metabolism in IgE receptor-mediated signal transduction. J Immunol. 1991 May 15;146(10):3528–3535. [PubMed] [Google Scholar]
  10. Forte T. M., McCall M. R., Knowles B. B., Shore V. G. Isolation and characterization of lipoproteins produced by human hepatoma-derived cell lines other than HepG2. J Lipid Res. 1989 Jun;30(6):817–829. [PubMed] [Google Scholar]
  11. Gamble W., Vaughan M., Kruth H. S., Avigan J. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res. 1978 Nov;19(8):1068–1070. [PubMed] [Google Scholar]
  12. Gibson G. G., Orton T. C., Tamburini P. P. Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). Biochem J. 1982 Apr 1;203(1):161–168. doi: 10.1042/bj2030161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldstein J. L., Brown M. S. Regulation of the mevalonate pathway. Nature. 1990 Feb 1;343(6257):425–430. doi: 10.1038/343425a0. [DOI] [PubMed] [Google Scholar]
  14. Hong C. Y., Lin S. J., Chang M. S., Chiang B. N., Shen P. M., Shiao M. S. Effect of pravastatin on fatty acid profile of low density lipoprotein in patients with hypercholesterolemia. Prostaglandins Leukot Essent Fatty Acids. 1993 Feb;48(2):155–158. doi: 10.1016/0952-3278(93)90104-5. [DOI] [PubMed] [Google Scholar]
  15. Jakóbisiak M., Bruno S., Skierski J. S., Darzynkiewicz Z. Cell cycle-specific effects of lovastatin. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3628–3632. doi: 10.1073/pnas.88.9.3628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Javitt N. B. Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J. 1990 Feb 1;4(2):161–168. doi: 10.1096/fasebj.4.2.2153592. [DOI] [PubMed] [Google Scholar]
  17. Kaluzny M. A., Duncan L. A., Merritt M. V., Epps D. E. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res. 1985 Jan;26(1):135–140. [PubMed] [Google Scholar]
  18. Kawashima Y., Musoh K., Kozuka H. Peroxisome proliferators enhance linoleic acid metabolism in rat liver. Increased biosynthesis of omega 6 polyunsaturated fatty acids. J Biol Chem. 1990 Jun 5;265(16):9170–9175. [PubMed] [Google Scholar]
  19. Kreuzer J., Bader J., Jahn L., Hautmann M., Kübler W., Von Hodenberg E. Chemotaxis of the monocyte cell line U937: dependence on cholesterol and early mevalonate pathway products. Atherosclerosis. 1991 Oct;90(2-3):203–209. doi: 10.1016/0021-9150(91)90116-k. [DOI] [PubMed] [Google Scholar]
  20. Lee J. H., Ikeda I., Sugano M. Dietary cholesterol influences on various lipid indices and eicosanoid production in rats fed dietary fat desirable for the protection of ischemic heart disease. J Nutr Sci Vitaminol (Tokyo) 1991 Aug;37(4):389–399. doi: 10.3177/jnsv.37.389. [DOI] [PubMed] [Google Scholar]
  21. Leikin A. I., Brenner R. R. Cholesterol-induced microsomal changes modulate desaturase activities. Biochim Biophys Acta. 1987 Dec 14;922(3):294–303. doi: 10.1016/0005-2760(87)90052-x. [DOI] [PubMed] [Google Scholar]
  22. Leikin A. I., Brenner R. R. In vivo cholesterol removal from liver microsomes induces changes in fatty acid desaturase activities. Biochim Biophys Acta. 1988 Nov 25;963(2):311–319. doi: 10.1016/0005-2760(88)90296-2. [DOI] [PubMed] [Google Scholar]
  23. Lock E. A., Mitchell A. M., Elcombe C. R. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu Rev Pharmacol Toxicol. 1989;29:145–163. doi: 10.1146/annurev.pa.29.040189.001045. [DOI] [PubMed] [Google Scholar]
  24. Lorenz R. L., Uedelhoven W. M., Fischer S., Ruetzel A., Weber P. C. A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator. Biochim Biophys Acta. 1989 Dec 8;993(2-3):259–265. doi: 10.1016/0304-4165(89)90174-8. [DOI] [PubMed] [Google Scholar]
  25. Markwell M. A., Haas S. M., Bieber L. L., Tolbert N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978 Jun 15;87(1):206–210. doi: 10.1016/0003-2697(78)90586-9. [DOI] [PubMed] [Google Scholar]
  26. Mercenne F., Goudonnet H., Mounie J., Escousse A., Truchot R. C. Effects of simvastatin, a lipoprotein-lowering drug, on the hepatic enzymes involved in drug metabolism in the Wistar rat. Xenobiotica. 1991 Jul;21(7):859–864. doi: 10.3109/00498259109039525. [DOI] [PubMed] [Google Scholar]
  27. Mimouni V., Christiansen E. N., Blond J. P., Ulmann L., Poisson J. P., Bezard J. Elongation and desaturation of arachidonic and eicosapentaenoic acids in rat liver. Effect of clofibrate feeding. Biochim Biophys Acta. 1991 Nov 27;1086(3):349–353. doi: 10.1016/0005-2760(91)90180-p. [DOI] [PubMed] [Google Scholar]
  28. Muriana F. J., Ruiz-Gutierrez V., Vazquez C. M. Influence of dietary cholesterol on polyunsaturated fatty acid composition, fluidity and membrane-bound enzymes in liver microsomes of rats fed olive and fish oil. Biochimie. 1992 Jun;74(6):551–556. doi: 10.1016/0300-9084(92)90153-6. [DOI] [PubMed] [Google Scholar]
  29. Ntambi J. M., Buhrow S. A., Kaestner K. H., Christy R. J., Sibley E., Kelly T. J., Jr, Lane M. D. Differentiation-induced gene expression in 3T3-L1 preadipocytes. Characterization of a differentially expressed gene encoding stearoyl-CoA desaturase. J Biol Chem. 1988 Nov 25;263(33):17291–17300. [PubMed] [Google Scholar]
  30. Pan H. Y., DeVault A. R., Wang-Iverson D., Ivashkiv E., Swanson B. N., Sugerman A. A. Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin. J Clin Pharmacol. 1990 Dec;30(12):1128–1135. doi: 10.1002/j.1552-4604.1990.tb01856.x. [DOI] [PubMed] [Google Scholar]
  31. Rodríguez-Vico F., Martínez-Cayuela M., García-Peregrín E., Ramírez H. A procedure for eliminating interferences in the lowry method of protein determination. Anal Biochem. 1989 Dec;183(2):275–278. doi: 10.1016/0003-2697(89)90479-x. [DOI] [PubMed] [Google Scholar]
  32. Russell D. W. Cholesterol biosynthesis and metabolism. Cardiovasc Drugs Ther. 1992 Apr;6(2):103–110. doi: 10.1007/BF00054556. [DOI] [PubMed] [Google Scholar]
  33. Singer I. I., Scott S., Kazazis D. M., Huff J. W. Lovastatin, an inhibitor of cholesterol synthesis, induces hydroxymethylglutaryl-coenzyme A reductase directly on membranes of expanded smooth endoplasmic reticulum in rat hepatocytes. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5264–5268. doi: 10.1073/pnas.85.14.5264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sánchez R. M., Viñals M., Alegret M., Vázquez M., Adzet T., Merlos M., Laguna J. C. Inhibition of rat liver microsomal fatty acid chain elongation by gemfibrozil in vitro. FEBS Lett. 1992 Mar 23;300(1):89–92. doi: 10.1016/0014-5793(92)80170-l. [DOI] [PubMed] [Google Scholar]
  35. Thrift R. N., Forte T. M., Cahoon B. E., Shore V. G. Characterization of lipoproteins produced by the human liver cell line, Hep G2, under defined conditions. J Lipid Res. 1986 Mar;27(3):236–250. [PubMed] [Google Scholar]
  36. Vincent T. S., Wülfert E., Merler E. Inhibition of growth factor signaling pathways by lovastatin. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1284–1289. doi: 10.1016/s0006-291x(05)81334-8. [DOI] [PubMed] [Google Scholar]
  37. Wang R. W., Kari P. H., Lu A. Y., Thomas P. E., Guengerich F. P., Vyas K. P. Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes. Arch Biochem Biophys. 1991 Nov 1;290(2):355–361. doi: 10.1016/0003-9861(91)90551-s. [DOI] [PubMed] [Google Scholar]
  38. Williams M. L., Menon G. K., Hanley K. P. HMG-CoA reductase inhibitors perturb fatty acid metabolism and induce peroxisomes in keratinocytes. J Lipid Res. 1992 Feb;33(2):193–208. [PubMed] [Google Scholar]
  39. Yeagle P. L. Modulation of membrane function by cholesterol. Biochimie. 1991 Oct;73(10):1303–1310. doi: 10.1016/0300-9084(91)90093-g. [DOI] [PubMed] [Google Scholar]
  40. Ziegler-Heitbrock H. W., Thiel E., Fütterer A., Herzog V., Wirtz A., Riethmüller G. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer. 1988 Mar 15;41(3):456–461. doi: 10.1002/ijc.2910410324. [DOI] [PubMed] [Google Scholar]
  41. van Doormaal J. J., Bos W. J., Muskiet F. A., Doorenbos H. Simvastatin influences linoleic acid metabolism. Pharm Weekbl Sci. 1989 Aug 25;11(4):134–135. doi: 10.1007/BF01987959. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES